Access cutting-edge brain tumor treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.
Access brain tumor specialists in Washington Dc at no cost
This study follows strict safety protocols and ethical guidelines
All study-related brain tumor treatment provided free
The purpose of this study is to measure the benefit of adding abemaciclib to the chemotherapy, temozolomide, for newly diagnosed high-grade glioma following radiotherapy. Your participation could last approximately 11 months and possibly longer depending upon how you and your tumor respond.
Sponsor: Eli Lilly and Company
Check if you qualify for this brain tumor clinical trial in Washington Dc, DC
If you're searching for brain tumor treatment options in Washington Dc, DC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced brain tumor specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.